InvestorsHub Logo
Followers 95
Posts 4782
Boards Moderated 0
Alias Born 02/07/2021

Re: flipper44 post# 675082

Wednesday, 02/28/2024 4:50:56 PM

Wednesday, February 28, 2024 4:50:56 PM

Post# of 688921
They can use potency assays and proteomic analysis not another trial. I don't see this as being a big deal for the handful of patients that would be in PI/II trials. It didn't stop Merck from running trials with DCVax at UCLA.

Though perhaps you are correct and we may not get notice of licensing deals, partnership, or buyout until Flaskworks gets GMP approval in UK. Though I am skeptical as the value seems already apparent.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News